PHOTOCIDE PROTECTION INC

Apex, NC · Medtech · Private

Light-activated antimicrobial wound dressings that produce reactive oxygen species to inactivate pathogens upon visible light illumination, with integrated self-contained illumination system for deep

Grants
$397K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Development and Commercialization of the SafeLight Family of Antimicrobial Materials for Combatting the COVID-19 Pandemic and Hospital Acquired Infections$225,000
Federal grantDepartment of Defense · Phase I · Antimicrobial Photodynamic Wound Dressings$171,836
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2164NANOMAG LLC—$4.0M
2165Confer, LLC—$2.0M
2166BIOMEMBRETICS, INC.——
2167PHOTOCIDE PROTECTION INC——
2168Neurometry——
2169COMPUTERIZED IMAGING REFERENCE SYSTEMS, INC.——
2170PRIOGEN CORP——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.